Sort
59,101 grants matching “hypertension”
Dopamine/Angiostensin Receptors in Genetic Hypertension
$1,981,272University Of Virginia Charlottesville · P01 · FY2005 · HL
Biology and Therapeutics of Cardiovascular Peptides
$1,981,154Mayo Clinic · P01 · FY2005 · HL
Hypoxic Adenosine Responses
$1,981,065Michael R Blackburn · University Of Texas Hlth Sci Ctr Houston · P01 · FY2014 · HL
EXERCISE OPTION PERIOD 2 FOR BPA ORDER TITLED "CONTENT DEVELOPMENT AND GRAPHIC/MEDICAL ARTS, IMAGING, AND BRAND MANAGEMENT" AGAINST THE NHLBI OSPEEC B
$1,980,447Thuy Pisone · Palladian Partners, Inc. · N02 · FY2022 · HL
Biology and Therapeutics of Cardiovascular Peptides
$1,979,640John C Burnett · Mayo Clinic Rochester · P01 · FY2007 · HL
Adaptation to Hypoxia
$1,979,638Kurt R Stenmark · University Of Colorado Denver · P01 · FY2018 · HL
Adaptation to Hypoxia
$1,979,638Kurt R Stenmark · University Of Colorado Denver · P01 · FY2017 · HL
Adaptation to Hypoxia
$1,979,638Kurt R Stenmark · University Of Colorado Denver · P01 · FY2019 · HL
SCOR: MOLECULAR GENETICS OF HYPERTENSION
$1,978,474Yale University · P50 · FY2004 · HL
Hopkins Center for Eliminate Cardiovascular Health Disparities
$1,978,113Lisa A Cooper · Johns Hopkins University · P50 · FY2011 · HL
Preserving Renal Function & Protective Immunity Via Anti-LFA1-Based CNI Avoidance
$1,978,098Kenneth A Newell · Emory University · U01 · FY2013 · AI
Genetics of Cardiovascular Disease
$1,977,901Gary Gibbons · National Human Genome Research Institute · ZIA · FY2014 · HG
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)
$1,976,808Alan Thevenet N. Tita · University Of Alabama At Birmingham · R01 · FY2024 · HL
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,976,439Julie A. Johnson · University Of Florida · U01 · FY2011 · GM
Dopamine/Angiostensin Receptors in Genetic Hypertension
$1,976,425Robin A Felder · University Of Virginia · P01 · FY2008 · HL
The Discovering Healthcare Innovations to Address Disparties in Stroke (DIADS) pr
$1,976,099Stephen Sidney · Kaiser Foundation Research Institute · U54 · FY2015 · NS
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,975,100Julie A. Johnson · University Of Florida · U01 · FY2014 · GM
IDENTIFYING GENES IN ABNORMAL BLOOD PRESSURE
$1,975,093Boston University Medical Campus · P50 · FY2004 · HL
NCHS-CDC NHIS Taste & Smell and NHIS Voice, Speech, and Language Questionnaire Supplements
$1,975,000Stephen Blumberg · National Institute On Deafness And Other Communication Disorders · Y01 · FY2022 · DC
Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics
$1,974,550Alain Gerald Bertoni · Wake Forest University Health Sciences · R01 · FY2015 · HL
Preserving Renal Function & Protective Immunity Via Anti-LFA1-Based CNI Avoidance
$1,974,106Kenneth A Newell · Emory University · U01 · FY2012 · AI
Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA
$1,972,025Susan Heckbert · University Of Washington · R01 · FY2017 · HL
Role of Eicosanoids in Renal Function
$1,972,009Jorge H Capdevila · Vanderbilt University · P01 · FY2009 · DK
Adaptations to Hypoxia
$1,971,570Kurt R Stenmark · University Of Colorado Denver · P01 · FY2013 · HL
Tulane COBRE in Hypertension and Renal Biology
$1,971,060Tulane University Of Louisiana · P20 · FY2005 · RR